InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP-248 for acute myeloid leukaemia: Beijing Friday, September 20, 2024, 18:00 Hrs [IST] InnoCare Pharma ...

Income inequality is on the rise, and this time, economists are coming for the dating apps. A recent National Post article ...

The Supreme Court has taken suo motu cognisance of allegedly controversial comments made by Karnataka High Court judge, ...

One Southern California school district found a way to reverse the low representation of Black and Latino students in science ...

While some designers envision a future where AI accelerates creativity and expands typographic possibilities, others worry ...

Xylem employs over 23,000 people globally and earned over $8 billion in revenue during 2023. Yet, Xylem's success stems from its local focus, working through employees and partners on the ground to ...

Gold’s months-long, record-breaking surge is keeping consumers at bay in China, tarnishing what should be one of the busiest ...

Bored with the same-old same-old when you're writing in Google Docs? You can make your Docs sparkle any way you like -- and ...

*All times Pacific *Schedule subject to change based on special events, simulcasts and breaking news.

BestColleges reports on a study that indicates the bachelor's degree will increasingly become the gateway to good jobs in the ...

“This game was so important for our confidence,” LePage said. “We’ve been working on some confidence issues that stem from ...

Lumentum, a market-leading designer and manufacturer of innovative optical and photonic products, announced its participation ...